The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients

Current guidelines suggest that HIV-infected patients should receive chemoprophylaxis against Pneumocystis jirovecii pneumonia (PJP) if they have a cluster determinant 4 (CD4) count 200 but CD4%

Saved in:
Bibliographic Details
Published in:Journal of the International Association of Providers of AIDS Care 2018-01, Vol.17, p.2325958218759199-2325958218759199
Main Authors: Anyimadu, Henry, Pingili, Chandra, Sivapalan, Vel, Hirsch-Moverman, Yael, Mannheimer, Sharon
Format: Article
Language:English
Subjects:
Antiretroviral drugs
Disease
HIV
Human immunodeficiency virus
Information technology
Medical records
Medicine
Original
Patients
Pneumonia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Current guidelines suggest that HIV-infected patients should receive chemoprophylaxis against Pneumocystis jirovecii pneumonia (PJP) if they have a cluster determinant 4 (CD4) count 200 but CD4%
ISSN:2325-9582
2325-9574
2325-9582
DOI:10.1177/2325958218759199